European Medicines Agency (EMA) has issued a Conditional Marketing Authorisation (CMA) ...

Medical Information

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you

This content is intended for French Healthcare Professionals. Would you like to proceed?

May 15, 2020

The European Medicines Agency has issued a conditional Marketing Authorisation to permit the use of COVID-19 mRNA vaccines COMIRNATY (tozinameran), COMIRNATY Original/Omicron BA.1 (tozinameran / riltozinameran) and COMIRNATY Original/Omicron BA.4/5 (tozinameran / famtozinameran).